Zai Lab

Zai Lab EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Zai Lab (ZLAB) as of Nov 22, 2026 is -6.50. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -4.58 — a change of 41.90% (lower).

EV/EBITDA

-6.50

YoY

41.90%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Zai Lab is 2025 -6.50 . EV/EBITDA (Enterprise Value to EBITDA) of Zai Lab was 2024 -4.58 . It decreases by 41.90% lower compared to the previous year.

The Zai Lab EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
-11.70 USD
Jan 1, 2019
-8.19 USD
Jan 1, 2020
-2.48 USD
Jan 1, 2021
-0.75 USD
Jan 1, 2022
-2.30 USD
Jan 1, 2023
-3.07 USD
Jan 1, 2024
-4.58 USD
Jan 1, 2025
-6.50 USD
The Zai Lab EV/EBITDA history
YEAREV/EBITDAYoY
-6.50+41.90%
-4.58+48.98%
-3.07+33.65%
-2.30+207.02%
-0.75-69.85%
-2.48-69.66%
-8.19-30.00%
-11.70-85.28%
-79.44+66.89%
-47.60-59.14%
-116.50—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zai Lab Stock analysis

What does Zai Lab do? Zai Lab Ltd, based in Pudong, China, is a biopharmaceutical company operating in the Health Care sector. It develops and commercializes innovative treatments for oncology, immunology, neuroscience, and infectious diseases. The company offers products such as Zejula for ovarian cancer, VYVGART for myasthenia gravis, NUZYRA for bacterial infections, Optune for brain tumors, Qinlock for gastrointestinal tumors, Xacduro for bacterial pneumonia, and Augtyro for lung cancer. Zai Lab collaborates with leading pharmaceutical firms including Pfizer and Amgen. Zai Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zai Lab stock

EV/EBITDA (Enterprise Value to EBITDA) of Zai Lab is -6.50 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Zai Lab changed from -4.58 to -6.50, representing a 41.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Zai Lab since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Zai Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Zai Lab

All Key Metrics — Zai Lab